Miracor Medical Systems is developing and commercializing disruptive therapy for patients with impaired cardiac function. PiCSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) is designed to improve clinical outcomes in patients affected by Acute Coronary Syndrome or heart failure.